1
|
Hattori Y, Ishimura M, Ohta Y, Takenaka H, Kawabata S, Kirihata M. Dodecaborate Conjugates Targeting Tumor Cell Overexpressing Translocator Protein for Boron Neutron Capture Therapy. ACS Med Chem Lett 2021; 13:50-54. [PMID: 35059123 PMCID: PMC8762747 DOI: 10.1021/acsmedchemlett.1c00377] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2021] [Accepted: 11/29/2021] [Indexed: 01/16/2023] Open
Abstract
We developed novel closo-dodecaborate ([B12H11]2-) anion-containing translocator protein (TSPO) ligand as a boron carrier for boron neutron capture therapy. This compound shows high water solubility and can deliver boron to TSPO highly expressed in breast cancer cells. We describe the synthesis and in vitro evaluation of a dodecaborate-based pyrazolopyrimidine.
Collapse
Affiliation(s)
- Yoshihide Hattori
- Research
Center of Boron Neutron Capture Therapy, Osaka Prefecture University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan,
| | - Miki Ishimura
- Research
Center of Boron Neutron Capture Therapy, Osaka Prefecture University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan,Stella
Pharma Co., ORIX Kouraibashi
Bldg., 3-2-7 Kouraibashi, Chuo-ku, Osaka 541-0043, Japan
| | - Youichirou Ohta
- Research
Center of Boron Neutron Capture Therapy, Osaka Prefecture University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan,Stella
Pharma Co., ORIX Kouraibashi
Bldg., 3-2-7 Kouraibashi, Chuo-ku, Osaka 541-0043, Japan
| | - Hiroshi Takenaka
- Research
Center of Boron Neutron Capture Therapy, Osaka Prefecture University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan,Stella
Pharma Co., ORIX Kouraibashi
Bldg., 3-2-7 Kouraibashi, Chuo-ku, Osaka 541-0043, Japan
| | - Shinji Kawabata
- Department
of Neurosurgery, Osaka Medical and Pharmaceutical
University, 2-7 Daigaku-machi, Takatsuki-shi, Osaka 569-8686, Japan
| | - Mitsunori Kirihata
- Research
Center of Boron Neutron Capture Therapy, Osaka Prefecture University, 1-1, Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan
| |
Collapse
|
2
|
Iacobazzi RM, Lopalco A, Cutrignelli A, Laquintana V, Lopedota A, Franco M, Denora N. Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. ChemMedChem 2017; 12:1261-1274. [PMID: 28771957 DOI: 10.1002/cmdc.201700322] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2017] [Revised: 07/06/2017] [Indexed: 11/10/2022]
Abstract
An interesting mitochondrial biomarker is the 18-kDa mitochondrial translocator protein (TSPO). Decades of study have shown that this protein plays an important role in a wide range of cellular functions, including opening of the mitochondrial permeability transition pore as well as programmed cell death and proliferation. Variations in TSPO expression have been correlated to different diseases, from tumors to endocrine and neurological disorders. TSPO has therefore become an appealing target for both early diagnosis and selective mitochondrial drug delivery. The number of structurally different TSPO ligands examined has increased over time, highlighting the scientific community's growing understanding of the roles of TSPO in normal and pathological conditions. However, only few TSPO ligands are characterized by the presence of groups that are potentially derivatizable; therefore only few such ligands are well suited for the preparation of targeted prodrugs or nanocarriers able to deliver therapeutics and/or diagnostic agents to mitochondria. This review provides an overview of the very few examples of drug delivery systems characterized by moieties that target TSPO.
Collapse
Affiliation(s)
| | - Antonio Lopalco
- Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy
| | - Annalisa Cutrignelli
- Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy
| | - Valentino Laquintana
- Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy
| | - Angela Lopedota
- Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy
| | - Massimo Franco
- Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy
| | - Nunzio Denora
- Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy
| |
Collapse
|
4
|
Strauch H, Engelmann J, Scheffler K, Mayer HA. A simple approach to a new T8-POSS based MRI contrast agent. Dalton Trans 2016; 45:15104-15113. [DOI: 10.1039/c6dt02365g] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
A simple synthesis of a new nanoglobular T8-silsesquioxane based contrast agent for the application in MRI is reported.
Collapse
Affiliation(s)
- Helene Strauch
- Institut für Anorganische Chemie
- Eberhard Karls Universität Tübingen
- 72076 Tübingen
- Germany
| | - Jörn Engelmann
- Hochfeld-Magnetresonanz-Zentrum
- Max-Planck-Institut für Biologische Kybernetik
- 72076 Tübingen
- Germany
| | - Klaus Scheffler
- Hochfeld-Magnetresonanz-Zentrum
- Max-Planck-Institut für Biologische Kybernetik
- 72076 Tübingen
- Germany
- Department of Biomedical Magnetic Resonance
| | - Hermann A. Mayer
- Institut für Anorganische Chemie
- Eberhard Karls Universität Tübingen
- 72076 Tübingen
- Germany
| |
Collapse
|
5
|
Srivastava P, Kaul A, Ojha H, Kumar P, Tiwari AK. Design, synthesis and biological evaluation of methyl-2-(2-(5-bromo benzoxazolone)acetamido)-3-(1H-indol-3-yl)propanoate: TSPO ligand for SPECT. RSC Adv 2016. [DOI: 10.1039/c6ra19514h] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The translator protein (TSPO, 18 kDa), a transmembrane mitochondrial protein, has been explored as an important biomarker by researchers for inflammation, immune modulation and cell proliferation. Here we report a new SPECT agent99mTc-MBIP for TSPO imaging and quantification.
Collapse
Affiliation(s)
- Pooja Srivastava
- Division of Cyclotron and Radiopharmaceutical Sciences
- Institute of Nuclear Medicine and Allied Sciences
- Delhi-110054
- India
- Molecular Neuroscience and Functional Genomics Laboratory
| | - Ankur Kaul
- Division of Cyclotron and Radiopharmaceutical Sciences
- Institute of Nuclear Medicine and Allied Sciences
- Delhi-110054
- India
| | - Himanshu Ojha
- Division of Cyclotron and Radiopharmaceutical Sciences
- Institute of Nuclear Medicine and Allied Sciences
- Delhi-110054
- India
| | - Pravir Kumar
- Molecular Neuroscience and Functional Genomics Laboratory
- Department of Biotechnology
- Delhi Technological University
- Delhi 110042
- India
| | - Anjani K. Tiwari
- Division of Cyclotron and Radiopharmaceutical Sciences
- Institute of Nuclear Medicine and Allied Sciences
- Delhi-110054
- India
| |
Collapse
|
6
|
Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions. Alzheimers Dement 2014; 11:1110-20. [DOI: 10.1016/j.jalz.2014.08.105] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2013] [Revised: 04/21/2014] [Accepted: 08/12/2014] [Indexed: 12/13/2022]
|